Search Results

There are 19465 results for: content related to: Enigmatic Role of Lipoprotein(a) in Cardiovascular Disease

  1. You have free access to this content
    Lipoprotein(a): resurrected by genetics

    Journal of Internal Medicine

    Volume 273, Issue 1, January 2013, Pages: 6–30, F. Kronenberg and G. Utermann

    Version of Record online : 12 NOV 2012, DOI: 10.1111/j.1365-2796.2012.02592.x

  2. Rhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms

    Journal of Medical Primatology

    Volume 44, Issue 3, June 2015, Pages: 117–124, Byambaa Enkhmaa, Adnan Abbuthalha, Erdembileg Anuurad, Wei Zhang, Alice F. Tarantal and Lars Berglund

    Version of Record online : 12 FEB 2015, DOI: 10.1111/jmp.12160

  3. Genetics of Lipoprotein(a) in Relation to Coronary Heart Disease

    Standard Article

    eLS

    Byambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang, Adnan Abbuthalha and Lars Berglund

    Published Online : 20 SEP 2013, DOI: 10.1002/9780470015902.a0025148

  4. Inhibition of Fibrinolysis by Lipoprotein(a)

    Annals of the New York Academy of Sciences

    Volume 936, Issue 1, June 2001, Pages: 261–275, EDUARDO ANGLÉS-CANO, AURORA DE LA PEÑA DÍAZ and STÉPHANE LOYAU

    Version of Record online : 25 JAN 2006, DOI: 10.1111/j.1749-6632.2001.tb03514.x

  5. Hormonal influences on lipoprotein(a) metabolism

    Diabetes, Obesity and Metabolism

    Volume 4, Issue 3, May 2002, Pages: 156–165, R. W. C. Pang and K. S. L. Lam

    Version of Record online : 30 MAY 2002, DOI: 10.1046/j.1463-1326.2002.00176.x

  6. Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome

    Clinical Endocrinology

    Volume 84, Issue 2, February 2016, Pages: 229–235, Byambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang, Adnan Abbuthalha, Parneet Kaur, Jasmeen Visla, Sidika Karakas and Lars Berglund

    Version of Record online : 5 OCT 2015, DOI: 10.1111/cen.12937

  7. You have free access to this content
    LPA gene: interaction between the apolipoprotein(a) size (‘kringle IV’ repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level

    Journal of Internal Medicine

    Volume 247, Issue 1, January 2000, Pages: 139–152, O. Røsby and K. Berg

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1365-2796.2000.00628.x

  8. You have free access to this content
    Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease

    Journal of Internal Medicine

    Volume 276, Issue 3, September 2014, Pages: 260–268, J. C. Hopewell, U. Seedorf, M. Farrall, S. Parish, T. Kyriakou, A. Goel, A. Hamsten, R. Collins, H. Watkins, R. Clarke and on behalf of the PROCARDIS Consortium

    Version of Record online : 5 FEB 2014, DOI: 10.1111/joim.12187

  9. Predictors of lipoprotein(a) levels in a European and South Asian population in the Newcastle Heart Project

    European Journal of Clinical Investigation

    Volume 33, Issue 8, August 2003, Pages: 686–692, A. Tavridou, N. Unwin, R. Bhopal and M. F. Laker

    Version of Record online : 16 JUL 2003, DOI: 10.1046/j.1365-2362.2003.01201.x

  10. Functional approach to investigate Lp(a) in ischaemic heart and cerebral diseases

    European Journal of Clinical Investigation

    Volume 33, Issue 2, February 2003, Pages: 99–105, A. De La Peña-Díaz, G. Cardoso-Saldaña, J. Zamora-González, F. Barinagarrementeria, R. Izaguirre, S. Loyau and E. Anglés-Cano

    Version of Record online : 13 FEB 2003, DOI: 10.1046/j.1365-2362.2003.01114.x

  11. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects

    Diabetic Medicine

    Volume 18, Issue 7, July 2001, Pages: 589–594, C. Gazzaruso, A. Garzaniti, C. Falcone, D. Geroldi, G. Finardi and P. Fratino

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1464-5491.2001.00536.x

  12. Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia

    Journal of Internal Medicine

    Volume 278, Issue 2, August 2015, Pages: 166–173, R. Vongpromek, S. Bos, G.-J. R. ten Kate, R. Yahya, A. J. M. Verhoeven, P. J. de Feyter, F. Kronenberg, J. E. Roeters van Lennep, E. J. G. Sijbrands and M. T. Mulder

    Version of Record online : 5 JAN 2015, DOI: 10.1111/joim.12335

  13. Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemia

    Clinical Genetics

    Volume 60, Issue 3, September 2001, Pages: 188–197, H Kim, SM Marcovina, KL Edwards, B McKnight, CM Bradley, MJ McNeely, BM Psaty, AG Motulsky and MA Austin

    Version of Record online : 12 JAN 2002, DOI: 10.1034/j.1399-0004.2001.600304.x

  14. Plasma lipoprotein (a) concentrations and apolipoprotein (a) phenotypes in an Aboriginal population from Western Australia

    Asia Pacific Journal of Clinical Nutrition

    Volume 9, Issue 3, September 2000, Pages: 235–240, Zuowei Xiong, Mark L Wahlqvist, Beryl Biegler, Nicholas DH Balazs, Paul Van Buynder and Naiyana Wattanapenpaiboon

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1440-6047.2000.00190.x

  15. Elevated Lp(a) with a small apo(a) isoform in children: risk factor for the development of premature coronary artery disease

    Acta Paediatrica

    Volume 97, Issue 12, December 2008, Pages: 1653–1657, Albert Dirisamer, Harald Widhalm, Elsie Aldover-Macasaet, Sylvia Molzer and Kurt Widhalm

    Version of Record online : 5 AUG 2008, DOI: 10.1111/j.1651-2227.2008.00979.x

  16. Impact of high lipoprotein(a) levels on in-stent restenosis and long-term clinical outcomes of angina pectoris patients undergoing percutaneous coronary intervention with drug-eluting stents in Asian population

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 6, June 2015, Pages: 588–595, Sang-Ho Park, Seung-Woon Rha, Byoung-Geol Choi, Ji-Young Park, Ung Jeon, Hong-Seog Seo, Eung-Ju Kim, Jin-Oh Na, Cheol-Ung Choi, Jin-Won Kim, Hong-Euy Lim, Chang-Gyu Park and Dong-Joo Oh

    Version of Record online : 4 JUN 2015, DOI: 10.1111/1440-1681.12396

  17. You have free access to this content
    Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation

    Journal of Thrombosis and Haemostasis

    Volume 6, Issue 12, December 2008, Pages: 2113–2120, N. T. FERIC, M. B. BOFFA, S. M. JOHNSTON and M. L. KOSCHINSKY

    Version of Record online : 4 OCT 2008, DOI: 10.1111/j.1538-7836.2008.03183.x

  18. Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: Influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene

    Hemodialysis International

    Volume 16, Issue 4, October 2012, Pages: 481–490, Sandra Ribeiro, Maria do Sameiro Faria, Gil Silva, Henrique Nascimento, Petronila Rocha-Pereira, Vasco Miranda, Emília Vieira, Rosário Santos, Denisa Mendonça, Alexandre Quintanilha, Elísio Costa, Luís Belo and Alice Santos-Silva

    Version of Record online : 20 APR 2012, DOI: 10.1111/j.1542-4758.2012.00687.x

  19. Are lipid-dependent indicators of cardiovascular risk affected by renal transplantation?

    Clinical Transplantation

    Volume 14, Issue 2, April 2000, Pages: 139–146, Antonio Schena, Salvatore Di Paolo, Luigi F Morrone, Francesco Resta, Giovanni Stallone and F Paolo Schena

    Version of Record online : 25 DEC 2001, DOI: 10.1034/j.1399-0012.2000.140207.x

  20. Role of various tissues in apo(a) fragmentation and excretion of fragments by the kidney

    European Journal of Clinical Investigation

    Volume 31, Issue 6, June 2001, Pages: 504–512, S. Frank, A. Hrzenjak, A. Blaschitz, G. Dohr and G. M. Kostner

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1365-2362.2001.00811.x